Literature DB >> 30558963

Alopecia areata: A multifactorial autoimmune condition.

Teontor Simakou1, John P Butcher2, Stuart Reid3, Fiona L Henriquez4.   

Abstract

Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body. It can later progress to total loss of scalp hair (Alopecia totalis) and/or total loss of all body hair (Alopecia universalis). The rapid rate of hair loss and disfiguration caused by the condition causes anxiety on patients and increases the risks of developing psychological and psychiatric complications. Hair loss in alopecia areata is caused by lymphocytic infiltrations around the hair follicles and IFN-γ. IgG antibodies against the hair follicle cells are also found in alopecia areata sufferers. In addition, the disease coexists with other autoimmune disorders and can come secondary to infections or inflammation. However, despite the growing knowledge about alopecia areata, the aetiology and pathophysiology of disease are not well defined. In this review we discuss various genetic and environmental factors that cause autoimmunity and describe the immune mechanisms that lead to hair loss in alopecia areata patients.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Alopecia areata; Autoreactive lymphocytes; Infection; JAK inhibitors; Oxidative stress; Polygenic autoimmune disease

Mesh:

Substances:

Year:  2018        PMID: 30558963     DOI: 10.1016/j.jaut.2018.12.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  27 in total

Review 1.  Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  [Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].

Authors:  Shi-Hai Zhou; Ya-Qun Xiong; Ya Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

3.  A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.

Authors:  Daniela Mikhaylov; Jacob W Glickman; Ester Del Duca; John Nia; Peter Hashim; Giselle K Singer; Alba L Posligua; Aleksandra G Florek; Erin Ibler; Erika L Hagstrom; Yeriel Estrada; Stephanie M Rangel; Maria Colavincenzo; Amy S Paller; Emma Guttman-Yassky
Journal:  Arch Dermatol Res       Date:  2022-03-01       Impact factor: 3.017

Review 4.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

5.  Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus.

Authors:  Karina Lopes Morais; Pedro Secchin; Alessandra Anzai; Maria Júlia Miquelão Canuto Verussa; Andréia Munck; Carolina Oliveira Costa Fechine; Neusa Yuriko Sakai Valente; Ricardo Romiti
Journal:  Skin Appendage Disord       Date:  2022-02-14

Review 6.  Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.

Authors:  Bo Xie; Jiayi Sun; Xiuzu Song
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

7.  Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study.

Authors:  Wenxin Zhang; Xiangqian Li; Baifu Chen; Jianzhong Zhang; Kara Melissa T Torres-Culala; Cheng Zhou
Journal:  Front Med (Lausanne)       Date:  2022-06-21

8.  Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report.

Authors:  Vikash Paudel; Deepa Chudal; Manish Bhakta Pradhan; Rupa Thakur; Buddhi Raj Pandey
Journal:  JNMA J Nepal Med Assoc       Date:  2021-09-11       Impact factor: 0.556

9.  Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Khalaf Kridin; Yaron Sela; Arnon Cohen
Journal:  Acta Derm Venereol       Date:  2022-03-14       Impact factor: 3.875

Review 10.  The Human Skin Microbiome in Selected Cutaneous Diseases.

Authors:  Silvia Carmona-Cruz; Luz Orozco-Covarrubias; Marimar Sáez-de-Ocariz
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.